What is Kenvue's market cap?

Kenvue (KVUE) has a market capitalization of $37.0B and trades on NYSE.

What is Kenvue's revenue and profitability?

Kenvue generated $15.3B in trailing twelve-month revenue with net income of $1.6B, representing a net margin of 10.6%. Gross margin stands at 58.4%, with free cash flow of $1.8B. These figures are based on the Q1 2026 filing.

Who are Kenvue's competitors?

Kenvue's key competitors include Procter & Gamble, Colgate-Palmolive, Kimberly-Clark, and others. These companies compete in similar markets and product categories.

Who does Kenvue partner with?

Kenvue's notable partners include Kimberly-Clark Corporation, Johnson & Johnson.

What subsidiaries does Kenvue have?

Kenvue's subsidiaries include Vesta Sub I, Inc..

Where is Kenvue headquartered?

Kenvue is headquartered in United States of America and employs approximately 22,000 people. It has been publicly traded since 2023.

Kenvue

KVUE

Kenvue is the world's largest pure-play consumer health company, specializing in science-backed personal care and over-the-counter products.

Market cap

$37.04B-8.4%

Revenue$15.3B-0.1%

Net income$1.6B+53.6%

Free cash flow$1.8B+25.7%

EPS (diluted)$0.85+51.8%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$3.9BBeat by $64.1M EPS$0.32Beat by $0.05

Read the full report

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$4.0B

EPS estimate$0.32

Financials

Q1 2026

Income statement

See full

Revenue$3.9B+4.5%

Gross profit$2.3B+6.2%

Operating income$767.0M+37.5%

Net income$474.0M+47.2%

EPS (diluted)$0.25+47.1%

Balance sheet

See full

Cash & equivalents$1.1B+1.7%

Total debt$8.8B-8.3%

Total equity$10.6B+5.5%

Total assets$26.9B+2.3%

Cash flow

See full

Operating cash flow$489.0M+14.3%

CapEx$139.0M-22.3%

Free cash flow$350.0M+40.6%

Valuation & ratios

Valuation

See full

Market cap$37.04B-8.4%

Enterprise value$44.76B-8.3%

P/E22.8×-5.7×

P/S2.4×-0.2×

Profitability

See full

Gross margin58.4%+0.3pp

Operating margin17.2%+5.1pp

Net margin10.6%+3.7pp

FCF margin11.9%+2.4pp

Returns & leverage

See full

Return on equity15.7%+5.5pp

Debt / equity0.8×-0.1×

Current ratio1×+0.1×

Segments

By segment

See full

Self Care$1.7B+1.9%

Essential Health$1.2B+4.9%

Skin Health and Beauty$1.1B+8.4%

Competitors

By market cap

Procter & Gamble$345.56B-8.4%

Colgate-Palmolive$74.4B-1.0%

Kenvue$37.0B-8.4%

Kimberly-Clark$36.8B-16.0%

Estee Lauder Companies Inc.$29.6B-7.3%

Church & Dwight$22.8B-6.0%

Clorox$11.4B-26.2%

NexGel, Inc.$4.7M-76.8%

By revenue growth

Colgate-Palmolive+4.3%

Procter & Gamble+3.3%

Church & Dwight+2.2%

Estee Lauder Companies Inc.+0.3%

Kimberly-Clark+0.1%

Kenvue-0.1%

Clorox-3.7%

By net margin

Procter & Gamble19.16%+0.7pp

Kimberly-Clark12.8%-2.1pp

Church & Dwight11.81%+2.3pp

Clorox11.18%+1.3pp

Kenvue10.61%+3.7pp

Colgate-Palmolive10.21%-4.3pp

Estee Lauder Companies Inc.-1.67%0.0pp

Profile

Kenvue is the world's largest pure-play consumer health company, specializing in science-backed personal care and over-the-counter products. The company leverages a century of heritage and deep clinical expertise to provide daily health solutions across a global portfolio of iconic brands. Its value proposition centers on combining consumer insights with rigorous scientific standards to earn recommendations from healthcare professionals and long-term trust from consumers.

Competitive position

Kenvue is the global leader in pure-play consumer health, maintaining top-tier market share through a portfolio of science-backed, professional-recommended brands.

GeographiesNorth America, Asia Pacific, Europe, Middle East, Africa, Latin America

Customer segmentsMass market consumers, Healthcare professionals, Retailers

Business modelB2C Brand Manufacturing, Omnichannel Retail, Direct-to-Consumer

SuppliersRaw material suppliers (resins, silicon, pulp, vegetable oils), Third-party contract manufacturers, Packaging material providers, Academic and research institutions

CustomersMass market retailers, Pharmacies and drugstores, E-commerce platforms, Direct-to-consumer shoppers

CountryUnited States of America

Listed2023

Employees22.0K

CEOKirk L. Perry

SectorConsumer Defensive

IndustryHousehold & Personal Products

Websitekenvue.com

FilingsSEC EDGAR

Ask your AI about Kenvue.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kenvue's market cap?: Kenvue (KVUE) has a market capitalization of $37.0B and trades on NYSE.
What is Kenvue's revenue and profitability?: Kenvue generated $15.3B in trailing twelve-month revenue with net income of $1.6B, representing a net margin of 10.6%. Gross margin stands at 58.4%, with free cash flow of $1.8B. These figures are based on the Q1 2026 filing.
Who are Kenvue's competitors?: Kenvue's key competitors include Procter & Gamble, Colgate-Palmolive, Kimberly-Clark, and others. These companies compete in similar markets and product categories.
Who does Kenvue partner with?: Kenvue's notable partners include Kimberly-Clark Corporation, Johnson & Johnson.
What subsidiaries does Kenvue have?: Kenvue's subsidiaries include Vesta Sub I, Inc..
Where is Kenvue headquartered?: Kenvue is headquartered in United States of America and employs approximately 22,000 people. It has been publicly traded since 2023.